Politics

Tracking how politics and policy intersect with science and health care

Chuck Grassley
Politics

Sen. Chuck Grassley takes your questions on drug prices, insulin, and innovation

By STAT staff

Cigarette all alone
Politics

New life for an old battle: Trump plan to remove tobacco regulation from FDA draws fire

By Nicholas Florko

Jaime Herrera Beutler
Politics

In reelection bid, a GOP lawmaker campaigns on Pelosi’s drug pricing bill

By Lev Facher

Ash tray
Politics

Trump doesn’t want the FDA to regulate tobacco

By Nicholas Florko

Pete Buttigieg
Politics

In their words: Warren, Buttigieg, Klobuchar, and other Democrats explain exactly how they’d lower drug prices

By Andrew Joseph

Politics

A closer look at Bernie Sanders’ plans to upend pharma and lower drug prices

By Lev Facher

Antoine Blonde/vaping hearing feb 2020
Politics

Juul and other e-cig makers to Congress: FDA, not you, should regulate us

By Nicholas Florko

Pete Buttigieg
Politics

A closer look at Pete Buttigieg’s aggressive, wonky plan to lower drug prices

By Lev Facher

State of the Union
Politics

Democrats interrupted Trump’s State of the Union to chant about their drug pricing bill

By Lev Facher and Nicholas Florko

Sen. Warren Attends Iowa Caucus
Politics

A bright spot amid the Iowa chaos: People with disabilities get an accessible caucus location

By Mark Satter and Chiara Vercellone

Wide shot insulin protest Cambridge
Politics

More than a dozen Democrats are bringing people with sky-high insulin bills to the State of the Union

By Nicholas Florko

D. Trump
Politics

Sensing an advantage, Democrats dare Trump to talk drug prices during State of the Union

By Lev Facher and Nicholas Florko

drug pricing
Politics

Employers shoulder plenty of drug costs, but haven’t lobbied much to lower them — until now

By Nicholas Florko

Seema Verma
Politics

Trump’s Medicaid changes offer states new powers to lower drug costs — with a catch

By Lev Facher

Alex Azar/HHS
Politics

A coronavirus ‘czar’? Trump took the opposite course: a 12-member committee

By Maggie Fox

FDA
Politics

With new rules, FDA aims to spark competition, lower prices for expensive gene therapies

By Nicholas Florko

Harvard campus gates
Politics

Top Harvard chemist charged with lying about ties to Chinese government program

By Rebecca Robbins

Alex Azar
Politics

Federal officials tell China: Let U.S. health workers enter to help respond to coronavirus

By Lev Facher

Pile of receipts
Politics

Want to know how contentious drug pricing is in Washington? Check the receipts

By Nicholas Florko

Donald Trump Davos 2020
Politics

Trump: Despite U.S. case, China virus is ‘under control’

By Lev Facher

Rep. Chris Collins January 2020
Biotech

Former Rep. Chris Collins sentenced to 26 months in prison in biotech insider trading scheme

By Damian Garde and Lev Facher

Alex Brandon/AP
Politics

Airing frustrations with pharma, a Republican FTC commissioner just endorsed Medicare negotiation

By Lev Facher

prescription drug pricing/NH
Politics

A court struck down a ban on pharma ‘price gouging.’ One state wants to revive it — and others could follow

By Lev Facher

des moines debate
Politics

Democrats zero in on high drug prices in Iowa debate

By Lev Facher

Hidden data
Politics

FDA and NIH let clinical trial sponsors keep results secret, investigation shows

By Charles Piller — Science

Chuck Grassley Feb. 2019
Politics

Trump should do more to bolster Senate drug pricing effort, Grassley says

By Lev Facher

American Action Network ad
Politics

Conservative group with pharma ties makes clear there are drug pricing reforms they can support

By Nicholas Florko

Road to nowhere
Politics

Washington took a decade to approve an obscure drug-pricing bill. That’s a bad omen for more ambitious reforms

By Nicholas Florko

cannabidiol
Politics

A spate of new class-action lawsuits threaten the CBD industry. Will they force Washington to act?

By Nicholas Florko

Your daily dose of news in health and medicine

Privacy Policy